What are the goals of prenatal genetic testing?

Stephanie Dukhovny, Mary E. Norton

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The landscape of genetic testing and screening has changed tremendously since the initial description of the molecular structure of DNA. Given this, it is critical that providers reflect on the goals of prenatal screening and diagnostic testing, and how these tests impact perinatal outcomes. The participants of this workshop were in agreement that the goal of prenatal genetic testing should be focused on improving outcomes for women and families. While prenatal testing has historically focused on the option for pregnancy termination, increasing numbers of prenatal and perinatal treatments are available. As more in utero therapies are developed, the detection of disorders that are amenable to, and would benefit from, prenatal or immediate neonatal targeted therapy will increasingly be a focus of prenatal testing. Prenatal genetic testing must also balance the ethical principles of autonomy and distributive justice. The workshop participants agreed that stakeholders such as medical professionals, professional societies, insurers, commercial laboratories, and the public should consider and come to agreement regarding the appropriate objectives for and use of these tests.

Original languageEnglish (US)
Pages (from-to)270-274
Number of pages5
JournalSeminars in Perinatology
Volume42
Issue number5
DOIs
StatePublished - Aug 1 2018

Fingerprint

Genetic Testing
Education
Insurance Carriers
Social Justice
Molecular Structure
Prenatal Diagnosis
Routine Diagnostic Tests
Therapeutics
Pregnancy
DNA

Keywords

  • aneuploidy screening
  • Down syndrome
  • prenatal diagnosis
  • Prenatal screening

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

What are the goals of prenatal genetic testing? / Dukhovny, Stephanie; Norton, Mary E.

In: Seminars in Perinatology, Vol. 42, No. 5, 01.08.2018, p. 270-274.

Research output: Contribution to journalReview article

Dukhovny, Stephanie ; Norton, Mary E. / What are the goals of prenatal genetic testing?. In: Seminars in Perinatology. 2018 ; Vol. 42, No. 5. pp. 270-274.
@article{f90fd932f0d941dc87f067e507a71398,
title = "What are the goals of prenatal genetic testing?",
abstract = "The landscape of genetic testing and screening has changed tremendously since the initial description of the molecular structure of DNA. Given this, it is critical that providers reflect on the goals of prenatal screening and diagnostic testing, and how these tests impact perinatal outcomes. The participants of this workshop were in agreement that the goal of prenatal genetic testing should be focused on improving outcomes for women and families. While prenatal testing has historically focused on the option for pregnancy termination, increasing numbers of prenatal and perinatal treatments are available. As more in utero therapies are developed, the detection of disorders that are amenable to, and would benefit from, prenatal or immediate neonatal targeted therapy will increasingly be a focus of prenatal testing. Prenatal genetic testing must also balance the ethical principles of autonomy and distributive justice. The workshop participants agreed that stakeholders such as medical professionals, professional societies, insurers, commercial laboratories, and the public should consider and come to agreement regarding the appropriate objectives for and use of these tests.",
keywords = "aneuploidy screening, Down syndrome, prenatal diagnosis, Prenatal screening",
author = "Stephanie Dukhovny and Norton, {Mary E.}",
year = "2018",
month = "8",
day = "1",
doi = "10.1053/j.semperi.2018.07.002",
language = "English (US)",
volume = "42",
pages = "270--274",
journal = "Seminars in Perinatology",
issn = "0146-0005",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - What are the goals of prenatal genetic testing?

AU - Dukhovny, Stephanie

AU - Norton, Mary E.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - The landscape of genetic testing and screening has changed tremendously since the initial description of the molecular structure of DNA. Given this, it is critical that providers reflect on the goals of prenatal screening and diagnostic testing, and how these tests impact perinatal outcomes. The participants of this workshop were in agreement that the goal of prenatal genetic testing should be focused on improving outcomes for women and families. While prenatal testing has historically focused on the option for pregnancy termination, increasing numbers of prenatal and perinatal treatments are available. As more in utero therapies are developed, the detection of disorders that are amenable to, and would benefit from, prenatal or immediate neonatal targeted therapy will increasingly be a focus of prenatal testing. Prenatal genetic testing must also balance the ethical principles of autonomy and distributive justice. The workshop participants agreed that stakeholders such as medical professionals, professional societies, insurers, commercial laboratories, and the public should consider and come to agreement regarding the appropriate objectives for and use of these tests.

AB - The landscape of genetic testing and screening has changed tremendously since the initial description of the molecular structure of DNA. Given this, it is critical that providers reflect on the goals of prenatal screening and diagnostic testing, and how these tests impact perinatal outcomes. The participants of this workshop were in agreement that the goal of prenatal genetic testing should be focused on improving outcomes for women and families. While prenatal testing has historically focused on the option for pregnancy termination, increasing numbers of prenatal and perinatal treatments are available. As more in utero therapies are developed, the detection of disorders that are amenable to, and would benefit from, prenatal or immediate neonatal targeted therapy will increasingly be a focus of prenatal testing. Prenatal genetic testing must also balance the ethical principles of autonomy and distributive justice. The workshop participants agreed that stakeholders such as medical professionals, professional societies, insurers, commercial laboratories, and the public should consider and come to agreement regarding the appropriate objectives for and use of these tests.

KW - aneuploidy screening

KW - Down syndrome

KW - prenatal diagnosis

KW - Prenatal screening

UR - http://www.scopus.com/inward/record.url?scp=85053071763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053071763&partnerID=8YFLogxK

U2 - 10.1053/j.semperi.2018.07.002

DO - 10.1053/j.semperi.2018.07.002

M3 - Review article

VL - 42

SP - 270

EP - 274

JO - Seminars in Perinatology

JF - Seminars in Perinatology

SN - 0146-0005

IS - 5

ER -